Perinatal lead exposure alters locomotion induced by amphetamine analogs in rats

Life Sciences

Volumn 88, Issue 13-14, 2011, Pages 586-589

  Clifford, P Shane ^a   Hart, Nigel ^a   Rothman, Richard B ^b   Blough, Bruce E ^c   Bratton, Gerald R ^d   Wellman, Paul J ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c RTI INTERNATIONAL   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Amphetamine; Body weight; Lead; Locomotion; Monoamine

Indexed keywords

AMPHETAMINE DERIVATIVE; DOPAMINE; LEAD; NORADRENALIN; PAL 287; PAL 353; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL INTERACTION; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; DRUG SENSITIVITY; EXPOSURE; FEMALE; LEAD BLOOD LEVEL; LOCOMOTION; MALE; NEUROCHEMISTRY; NONHUMAN; NORADRENALIN RELEASE; PERINATAL PERIOD; RAT; SEROTONIN RELEASE; TISSUE LEVEL;

AMPHETAMINES; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; LEAD; MALE; MOTOR ACTIVITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; TISSUE DISTRIBUTION;

RATTUS;

EID: 79952705779     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.01.007     Document Type: Article

References (22)

1. Devoto P, Flore G, Ibba A, Fratta W, Pani L. Lead intoxication during intrauterine life and lactation but not during adulthood reduces nucleus accumbens dopamine release as studied by brain microdialysis. Toxicol Lett 2001;121:199-206. (Pubitemid 32441776)
2. Gulson BL, Jameson CW, Mahaffey KR, Mizon KJ, Korsch MJ, Vimpani G. Pregnancy increases mobilization of lead from maternal skeleton. J Lab Clin Med 1997;130:51-62. (Pubitemid 27340788)
3. Hall DA, Stanis JJ, Avila HM, Gulley JM. A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: evidence for qualitative differences in behavior. Psychopharmacology 2008;195:469-78. (Pubitemid 350160487)
4. Howell LL, Kimmel HL. Monoamine transporters and psychostimulant addiction. Biochem Pharmacol 2008;75(1):196-217 Jan 1.
5. Kirk RE. Experimental design: procedures for the behavioral sciences. Second ed. 1982. p. 83. Wadsworth, California Page.
6. Lasley SM. Regulation of dopaminergic activity, but not tyrosine hydroxylase, is diminished after chronic inorganic lead exposure. Neurotoxicology 1992;13(3):625-6 35 Fall.
7. Nation JR, Cardon AL, Heard HM, Valles R, Bratton GR. Perinatal lead exposure and relapse to drug-seeking behavior in the rat: a cocaine reinstatement study. Psychopharmacology 2003;168:236-43. (Pubitemid 36851185)
8. Nation JR, Miller DK, Bratton GR. Developmental lead exposure alters the stimulatory properties of cocaine at PND 30 and PND 90 in the rat. Neuropsychopharmacology 2000;23:444-54.
9. Nation JR, Smith KR, Bratton GR. Early developmental lead exposure increases sensitivity to cocaine in a self-administration paradigm. Pharmacol Biochem Behav 2004;77:127-35. (Pubitemid 38076989)
10. Negus SS, Mello NK, Blough BE, Baumann MH, Rothman RB. Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther 2007;320:627.
11. Roberts DC, Phelan R, Hodges LM, Hodges MM, Bennett B, Childers S, et al. Self-administration of cocaine analogs by rats. Psychopharmacology 1999;144(4):389-97. (Pubitemid 29307264)
12. Rocha A, Valles R, Cardon AL, Bratton GR, Nation JR. Self-administration of heroin in rats: effects of low-level lead exposure during gestation and lactation. Psychopharmacology 2004;174:203-10. (Pubitemid 38916293)
13. Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, et al. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 2001;479:23.
14. Rothman RB, Blough BE, Baumann MH. Appetite suppressants as agonist substitution therapies for stimulant dependence. Ann NY Acad Sci 2002;965:109-26. (Pubitemid 34721961)
15. Rothman RB, Blough BE, Woolverton WL, Anderson KG, Negus SS, Mello NK, et al. Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration. J Pharmacol Exp Ther 2005;313(3):1361-9. (Pubitemid 40727043)
16. Sandberg PR, Zoloty SA, Willis R, Ticarich CD, Rhoads K, Nagy RP, et al. Digiscan activity: automated measurement of thigmotactic and stereotypic behavior in rats. Pharmacol Biochem Behav 1987;27:569-72. (Pubitemid 17107033)
17. Szczerbak G, Nowak P, Kostrzewa RM, Brus R. Maternal lead exposure produces long-term enhancement of dopaminergic reactivity in rat offspring. Neurochem Res Oct 2007;32(10):1791-8. (Pubitemid 47428845)
18. Valles R, Rocha A, Cardon AL, Bratton GR, Nation JR. The effects of the GABAA antagonist bicuculline on cocaine self-administration in rats exposed to lead during gestation/ lactation. Pharmacol Biochem Behav 2005;80:611-9. (Pubitemid 41583210)
19. Virgolini MB, Chen K, Weston DD, Bauter MR, Cory-Slechta DA. Interactions of chronic lead exposure and intermittent stress: consequences for brain catecholamine systems and associated behaviors and HPA axis function. Toxicol Sci 2005;87(2):469-82 Oct.
20. Wee S, Anderson KG, Baumann MH, Rothman RB, Blough BE, Woolverton WL. Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J Pharmacol Exp Ther 2005;313:848.
21. Weizaecker K. Lead toxicity during pregnancy. Prim Care Obstet Gynecol 2003;10:304-9.
22. Wellman PJ, Davis KW, Clifford PS, Rothman RB, Blough BE. Changes in feeding and locomotion induced by amphetamine analogs in rats. Drug Alcohol Depend 2009;100:234-9.